PubMed

Trials that matter: two faces of progress in the treatment of age-related macular degeneration.

Epstein P.

Ann Intern Med. 2007 Apr 3;146(7):532-4. No abstract available. PMID: 17404357 [PubMed - indexed for MEDLINE]Related articlesFree article

Cheap shots and pricey propositions: evidence, disclosure, and treatment of age-related macular degeneration.

Kimmelman J.

Retina. 2007 Nov-Dec;27(9):1166-7. No abstract available. PMID: 18046219 [PubMed - indexed for MEDLINE]Related articles

Costs of treatment for age-related macular degeneration.

Gerson JD.

Optometry. 2009 Jul;80(7):339. No abstract available. PMID: 19753688 [PubMed - indexed for MEDLINE]Related articles

[Age-related macular degeneration and antivascular endothelial growth factor: a review]

Fajnkuchen F, Cohen SY.

J Fr Ophtalmol. 2008 Jan;31(1):94-110. French. PMID: 18401308 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical update: new treatments for age-related macular degeneration.

Wong TY, Liew G, Mitchell P.

Lancet. 2007 Jul 21;370(9583):204-6. No abstract available. PMID: 17658379 [PubMed - indexed for MEDLINE]Related articles

[New therapeutic aspects in age-related macular degeneration]

Adán A, Casaroli-Marano RP.

Med Clin (Barc). 2007 Nov 10;129(17):658-9. Spanish. No abstract available. PMID: 18005633 [PubMed - indexed for MEDLINE]Related articles

[Age-related macular degeneration: therapeutic hopes]

Behar-Cohen F, Sennlaub F, Berdugo M.

Med Sci (Paris). 2007 Feb;23(2):127-9. French. No abstract available. PMID: 17291419 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.

van Wijngaarden P, Qureshi SH.

Clin Exp Optom. 2008 Sep;91(5):427-37. Epub 2008 Jul 10. Review.PMID: 18637105 [PubMed - indexed for MEDLINE]Related articles

New treatments for age-related macular degeneration.

Avery RL.

Lancet. 2007 Oct 27;370(9597):1479-80; author reply 1480. No abstract available. PMID: 17964341 [PubMed - indexed for MEDLINE]Related articles

Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

Kourlas H, Abrams P.

Clin Ther. 2007 Sep;29(9):1850-61. Review.PMID: 18035187 [PubMed - indexed for MEDLINE]Related articles

Treatment of exudative age-related macular degeneration: many factors to consider.

Olsen TW.

Am J Ophthalmol. 2007 Aug;144(2):281-3. No abstract available. PMID: 17659955 [PubMed - indexed for MEDLINE]Related articlesFree article

Ranibizumab for neovascular age-related macular degeneration.

Gillies MC, Wong TY.

N Engl J Med. 2007 Feb 15;356(7):748-9; author reply 749-50. No abstract available. PMID: 17310523 [PubMed - indexed for MEDLINE]Related articles

Avastin versus Lucentis: ethical issues in treatment of age-related macular degeneration.

Klein RM, Klein RB.

Retina. 2007 Nov-Dec;27(9):1163-5. No abstract available. PMID: 18046218 [PubMed - indexed for MEDLINE]Related articles

[New drug treatment for age-related macular degeneration]

Stefánsson E, la Cour M, Helgadóttir G, Sigurdsson H, Jónasson F.

Laeknabladid. 2007 Apr;93(4):299-301. Icelandic. PMID: 17460341 [PubMed - indexed for MEDLINE]Related articles

[Bevacizumab: progress in the treatment of metastatic cancer and hope for patients with proliferative retinopathy]

Antoniak K, Nowak JZ.

Postepy Hig Med Dosw (Online). 2007 May 29;61:320-30. Review. Polish. PMID: 17554235 [PubMed - indexed for MEDLINE]Related articlesFree article

Regeneron focuses on age-related macular degeneration.

Wolfson W.

Chem Biol. 2008 Apr;15(4):303-4. No abstract available. PMID: 18420133 [PubMed - indexed for MEDLINE]Related articles

[Lucentis versus Avastin--is there a light at the end of the tunnel for age-related macular degeneration patients?]

Waisbourd M, Leibovitch I, Loewenstein A, Yassur Y.

Harefuah. 2008 Jul;147(7):605-6, 662. Hebrew. PMID: 18814519 [PubMed - indexed for MEDLINE]Related articles

[Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series]

Meyer CH, Helb HM, Eter N.

Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. Review. German. PMID: 18256841 [PubMed - indexed for MEDLINE]Related articles

[Treatment of neovascular age-related macular degeneration: an unresolved matter]

Flores-Moreno S, Bautista-Paloma J.

Arch Soc Esp Oftalmol. 2008 Jul;83(7):405-6. Spanish. No abstract available. PMID: 18592439 [PubMed - indexed for MEDLINE]Related articlesFree article

Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Ziemssen F, Heiduschka P, Schraermeyer U; Tübingen Bevacizumab Study Group.

Retina. 2007 Oct;27(8):1154-6; author reply 1156-8. No abstract available. PMID: 18040264 [PubMed - indexed for MEDLINE]Related articles